Rapid Rise in medical emergencies is leading to high demand for Heparin after the Covid 19 impact.
The Global Heparin Market was valued at USD 6.5 billion in 2020 and is expected to reach USD 9.7 billion by 2027, growing at a CAGR of 5.9% during the forecast period, 2021 - 2027.
Heparin doses are often used to treat a wide range of health problems such as deep vein thrombosis, acute coronary syndrome, atrial fibrillation, pulmonary embolism, and even cardiopulmonary bypass and hemofiltration during cardiac surgery, this extravagant usage is propelling the market growth. In addition, the supply of synthetic and semi-synthetic heparin mimetics that help treat cancer, coagulation, and inflammatory diseases is expected to provide a favorable opportunity for heparin adoption.
The Global Heparin Market Segmentation:
The global heparin market is segmented into product, application, distribution channel, route of administration, and region.
Company Profiles and Competitive Intelligence
The key players operating in the market are:
The report provides with an in-depth analysis of market trends, financial analysis, segmentation analysis, company profiles, recent news and much more. Heparin market is segmented into product, application, and distribution channel, route of administration, end use, and region. Based on product, the Low Molecular Weight Heparin (LMWH) segment is anticipated to hold the largest market in the forecast period. With longer predictable surgery and subcutaneous injections than UFH, easy self-management at home, reducing or eliminating hospitalizations and not requiring daily blood monitoring promotes the growth of low molecular weight heparin market segment. On the basis of applications, the coronary artery disease segment is accounted to dominate the market, owing to the increase in prevalence of heart- related disorders n past few years.
Geographically, the North American region is dominating the market with highest revenue. The supremacy is attributed to high healthcare expenditure, high healthcare related awareness and incorporation of enhanced and sophisticated healthcare infrastructure in the region. Moreover, the growing incidences of cardiovascular disorders and sports injuries are propelling the regional market growth. However, Asia pacific region is witnessing the highest CAGR in the upcoming years owing to the continuous developments in healthcare infrastructure, economic development, and untapped opportunities in these developing nations.
Report also covers analysis of some of the key players including Fresenius SE & Co KGaA, B. Braun Holding GmbH & Co. KG, Baxter International Inc., Dr. Reddy’s Laboratories Ltd., and Aspen Holdings among others. These players have significantly adopted varied developmental strategies covered on our reports. The report also covers numerous market trends and upcoming opportunities in the near future.
Global Heparin Market Report Highlights.